Navigation Links
Chigurupati Technologies Launches First Globally Disruptive Tech Out of India
Date:2/16/2017

Harsha Chigurupati knows the meaning of hard work and determination. After what took over 10 years of research, development and clinical trials, the founder of Chigurupati Technologies has invented India’s first globally disruptive technology, NTX Technology™. NTX Technology™ is a patented compound of FDA approved ingredients that when infused into alcohol, protect the consumer’s liver and DNA, without affecting the experience of drinking alcohol.

Harsha Chigurupati began working on NTX Technology™ in 2006, with initial steps of proof of concept based upon research papers, thorough molecular research and proven in vitro and in vivo trials. The research performed by his team of PhD scientists focused only on metabolic pathways that didn't impact the state of being intoxicated, and at the same time did not affect the way a person would enjoy drinking.

Understanding the potential complications of creating a safer way for consumers to enjoy spirits, the team sought to develop a technology that was stable in alcohol, adding minimal taste, and yet would be easily approved by any regulatory organizations. The scientists followed the “GRAS” or "generally recognized as safe" ingredient list approved by the Federal Drug Administration (FDA) and the TTB as a starting place then began molecular screening through trial and error to find compounds that would be stable in alcohol. Once the dosage of each element and the synergistic combination was optimized, the results were proven through human clinical trials.

The result: the creation of NTX Technology™, a proprietary, patented blend of Glycyrrhizin (Licorice Root Extract), Manna Sugar (Low Calorie Sugar Crystals found in fruits and plants) and Potassium Sorbate (White Salt).

Multiple human clinical trials, conducted in both India and the United States, found that alcohol infused with NTX technology™ reduced stress and protected the liver from alcohol induced stress by up to 93%. More astounding was the discovery that alcohol begins to cause damage to human DNA within a mere 15 minutes after consuming alcohol, and that NTX Technology™ also provides protection to the DNA. The damaged DNA can then mutate into diseased cells, changing the epigenetic expression of the genes, as well as increasing the probability of other possible complications such as allergies or even cancer.

Chigurupati Technologies has entered a partnership with Bellion Spirits, a US based spirits manufacturer, to introduce a full line of alcoholic beverages infused with NTX Technology™, pioneering a new alcohol industry category of Functional Spirits™ which are safer on the body than traditional spirits. Alcohol created with NTX Technology™ is already available in the United States.

“It is an exciting development in technology,” Chigurupati explained. “Over 2 billion people around the world drink alcoholic beverages on a regular basis, despite the known detrimental effects it can have on the body. To offer a safer, smarter option to consumers is an industry changing concept, soon to be accepted as the norm. It is similar to when the automobile was introduced to the market, it made horse drawn carriages obsolete.”

Chigurupati Technologies continues to develop additional technologies designed to improve consumers lives, reducing the impact of age accelerating elements and factors in everyday living. By leveraging and integrating these technologies into consumer goods, these advancements are made available and accessible to the mainstream market.

“Evolution is mankind’s ability to overcome natural limitations,” Chigurupati states. “Through our primary focus on research and development, Chigurupati Technologies develops new technologies that allow us to overcome such limitations. Integrating these developments into consumer goods, introducing to market in a fashion that does not change the way people experience, interact and enjoy these product, ensures they will choose these smarter options.”

For more information on Chigurupati Technologies please visit: http://www.chigurupati.com

For more information on NTX Technology please visit: http://www.DrinkSmarter.com

For press appearances or interviews please contact:
Kara A. Kenney
Vice President of Education and Communication
Chigurupati Technologies
E: kara.kenney(at)chigurupati(dot)com
T: 310.689.9178

                     #### #### ####
About:
Chigurupati Technologies is a research and development company dedicated to the development of innovative technologies that provide valuable health benefits through evolutionary consumer products. In 2006, Harsha Chigurupati, pharmaceutical executive, entrepreneur, and inventor, founded Chigurupati Technologies. His vision: to aid in the evolution of mankind, through the development of technologies that reduce and counter the impact of age accelerating environmental factors in our daily lives. Chigurupati Technologies leverages these disruptive technologies, implementing them into consumer products, ensuring mainstream access of these innovations to everyone. For information on Chigurupati Technologies visit: http://www.chigurupati.com/ .

Read the full story at http://www.prweb.com/releases/2017/02/prweb14075640.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Reichert Technologies - Life Sciences Showcases SPR Applications and Capabilities at 61st Annual Biophysical Society Meeting in New Orleans
2. Sensogram Technologies Names Telemedical Partners As North American Master Distributor
3. Critical Signal Technologies Names New Chief Operating Officer
4. Remote Medical Technologies’ Portable Teleultrasound Capabilities Show Innovative Progression in Teleradiology
5. Exploring the Latest Medical Technologies, as Innovations TV Show Features Stem Cell Theranostics
6. Orbita Announces Breakthrough in Voice Assistant Technologies for Home Healthcare
7. ODU-USA Advanced Contact Technologies for a Wide Range of Applications
8. Bioelectronic Medicine Pioneer, ElectroMedical Technologies, Announces Enhanced Platform, WellnessPro Plus to Expand Treatment Applications for Chronic and Acute Pain
9. Mammogram Technologies are Discussed on "Front Page Profile" with James Earl Jones
10. GTB Technologies to Showcase the Markets' First Integrated Content Aware Enterprise DRM Solution during the Gartner IAM Summit
11. OriGene Technologies and EdiGene Announce Joint Development of Genome Wide Knockout Cell Lysates, Revolutionizing Western Blot and Antibody Specificity Validation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... PORT RICHEY, Fla. (PRWEB) , ... February 27, 2017 , ... ... use disorder, but concern for women who become dependent on opioid painkillers has fallen ... among female patients, compared to a 237% increase in fatal overdoses in male populations.(1) ...
(Date:2/27/2017)... ... 2017 , ... Elisa Guajardo Carothers is not your typical author. She went from working as ... Now, she writes about God, when she isn’t swimming as a performing mermaid. , Her ... BS! (Before Satan),” she offers a comedic look at the dysfunctions of God’s family, before ...
(Date:2/27/2017)... ... February 27, 2017 , ... This webinar , sponsored ... a tool to characterize particle size distributions in the field of geoscience and ... novel scientific findings. It describes methods of optimized and standardized sample collection, preparation ...
(Date:2/27/2017)... ... 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the International Lyme ... Center for Disease Control ( CDC ) and Infectious Diseases Society of America (IDSA) ... has compiled into a single volume a compelling argument that the disease does exist ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to ... new hire, Mackenzie Alsager, showcases the Centre's commitment to innovation in drug rehab ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... ... Markets has announced the addition of the "Ovarian Cancer Drugs Price ... The latest research Ovarian Cancer Drugs Price Analysis and Strategies - ... market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Ovarian Cancer ...
(Date:2/28/2017)... , Feb. 28, 2017  Rigel Pharmaceuticals, Inc. ... it will report its fourth quarter and year ... March 7, 2017.  Rigel senior management will follow ... webcast at 5:00pm Eastern Time (2:00pm Pacific Time) ... can access the live conference call by dialing ...
(Date:2/28/2017)... , February 27, 2017 ... BioMedical assets for potential ... LOI contemplates capital infusion into Amarantus to assist ... Amarantus names four new appointees to its Board of Directors and ... SeD Biomedical Inc. (SeD Biomedical) , a ...
Breaking Medicine Technology: